DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
CNY 16.16
(0.56%)
CNY 16.16
(0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 24.43 Billion | 21.24 Billion | 16.75 Billion | 14.58 Billion | 11.14 Billion | 8.85 Billion |
| Cost of Revenue | 16.18 Billion | 13.21 Billion | 10.36 Billion | 8.97 Billion | 6.74 Billion | 5.16 Billion |
| Gross Profit | 8.24 Billion | 8.03 Billion | 6.39 Billion | 5.6 Billion | 4.39 Billion | 3.68 Billion |
| Operating Expenses | 7.17 Billion | 6.36 Billion | 5.19 Billion | 4.16 Billion | 3.44 Billion | 2.95 Billion |
| Selling, General and Administrative Expenses | 5.95 Billion | 5.46 Billion | 4.55 Billion | 3.67 Billion | 3.06 Billion | 2.62 Billion |
| Research and Development Expenses | 87.59 Million | 74.37 Million | 44.6 Million | 4.7 Million | 434.48 Thousand | 495.64 Thousand |
| Other Expenses | 193.29 Million | 822.99 Million | 603.88 Million | 480.52 Million | 388.34 Million | 1.25 Million |
| Cost and Expenses | 22.89 Billion | 19.58 Billion | 15.56 Billion | 13.13 Billion | 10.19 Billion | 8.12 Billion |
| Operating Income | 1.63 Billion | 1.42 Billion | 1.04 Billion | 1.44 Billion | 918.25 Million | 718.29 Million |
| Interest Expense | 275.33 Million | 48.23 Million | 212.04 Million | 11.49 Million | 32.05 Million | 23.97 Million |
| Income Tax Expense | 397.12 Million | 335.62 Million | 239.51 Million | 363.39 Million | 222.95 Million | 193.86 Million |
| Earnings before Tax | 1.62 Billion | 1.41 Billion | 1.04 Billion | 1.44 Billion | 919.49 Million | 719.55 Million |
| Net Income | 1.16 Billion | 1.03 Billion | 791.23 Million | 1.06 Billion | 702.66 Million | 531.63 Million |
| Earnings Per Share Basic | 1.03 | 0.91 | 0.70 | 0.94 | 0.63 | 0.49 |
| Earnings Per Share Diluted | 1.03 | 0.91 | 0.70 | 0.94 | 0.53 | 0.49 |
| Weighted Average Shares Outstanding | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.11 Billion | 1.07 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.32 Billion | 1.08 Billion |
| Gross Margin | 0.34 | 0.38 | 0.38 | 0.38 | 0.39 | 0.42 |
| EBIT Margin | 0.15 | 0.13 | 0.14 | 0.11 | 0.10 | 0.10 |
| Profit Margin | 0.05 | 0.05 | 0.05 | 0.07 | 0.06 | 0.06 |
| EBITDA | 3.59 Billion | 2.75 Billion | 2.64 Billion | 1.82 Billion | 1.26 Billion | 1 Billion |
| Earnings Before Tax Margin | 0.07 | 0.07 | 0.06 | 0.10 | 0.08 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 6.35 Billion | 6.56 Billion | 6.72 Billion | 6.77 Billion | 24.43 Billion | 5.73 Billion |
| Cost of Revenue | 4.2 Billion | 4.45 Billion | 4.35 Billion | 4.68 Billion | 16.18 Billion | 3.65 Billion |
| Gross Profit | 2.15 Billion | 2.11 Billion | 2.37 Billion | 2.08 Billion | 8.24 Billion | 2.07 Billion |
| Operating Expenses | 1.85 Billion | 1.75 Billion | 1.76 Billion | 2.07 Billion | 6.47 Billion | 1.64 Billion |
| Selling, General and Administrative Expenses | 1.84 Billion | 1.72 Billion | 1.75 Billion | 1.97 Billion | - | 2.01 Billion |
| Research and Development Expenses | 18.12 Million | 16.69 Million | 12.79 Million | 44.88 Million | - | 11.6 Million |
| Other Expenses | 3.58 Million | -9.09 Million | -2.18 Million | -56.94 Million | -15.77 Million | -7.94 Million |
| Cost and Expenses | 6.06 Billion | 6.2 Billion | 6.12 Billion | 6.75 Billion | 22.65 Billion | 5.3 Billion |
| Operating Income | 298.41 Million | 358.65 Million | 604.4 Million | 14.57 Million | 1.77 Billion | 371.62 Million |
| Interest Expense | 51.78 Million | - | 62.24 Million | -115.51 Million | 66.21 Million | 61.52 Million |
| Income Tax Expense | 65.47 Million | 81.44 Million | 118.3 Million | 29.4 Million | 397.12 Million | 95.05 Million |
| Earnings before Tax | 278.43 Million | 328.85 Million | 571.99 Million | 37.48 Million | 1.62 Billion | 363.68 Million |
| Net Income | 200.52 Million | 259.14 Million | 398.45 Million | -7.86 Million | 1.16 Billion | 256.93 Million |
| Earnings Per Share Basic | 0.18 | 0.23 | 0.35 | -0.01 | - | 0.23 |
| Earnings Per Share Diluted | 0.18 | 0.23 | 0.35 | -0.01 | - | 0.23 |
| Weighted Average Shares Outstanding | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.13 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.13 Billion | 1.13 Billion |
| Gross Margin | 0.34 | 0.32 | 0.35 | 0.31 | 0.34 | 0.36 |
| EBIT Margin | 0.05 | 0.12 | 0.10 | 0.07 | - | 0.07 |
| Profit Margin | 0.03 | 0.04 | 0.06 | -0.00 | 0.05 | 0.04 |
| EBITDA | 330.21 Million | 815.18 Million | 643.06 Million | 467.64 Million | - | 428.98 Million |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.09 | 0.00 | 0.07 | 0.06 |
KRYPY
PSBQ
IRB
0IL6
002031
2761